Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide Monotherapy in Japanese Patients with Type 2 Diabetes
NCT01960179Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2013
- Primary completion
- Mar 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Nov 2013; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01960179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01960179.